We’re collecting info on Kesimpta® When Taken During Pregnancy
MotherToBaby is currently enrolling participants into an observational study examining the use of Kesimpta® (ofatumumab) when taken shortly before or during pregnancy. Our studies are strictly observational, which means we will never ask you to take any new medicines, experimental drugs or to change any part of your healthcare routine. If you enroll, you’ll simply be followed by our team through the remainder of your pregnancy, and your baby will be followed for a period of time after birth.
Our goal is to provide parents and their health providers with the evidence-based information that they need to make more informed healthcare decisions during pregnancy. To do that, we need your help. If you have multiple sclerosis and have taken Kesimpta® (ofatumumab) at any point in your current pregnancy, or 5 1/2 months prior to pregnancy, you may qualify for this important study.
Questions?
To connect with our research team, please contact us at
Phone | 877.311.8972
Email | mothertobaby@health.ucsd.edu
We’re open Monday – Thursday from 7am – 7pm and Friday 7am – 6pm Pacific, excluding public holidays.
You can also visit our Frequently Asked Questions to learn more about participating in our studies.
How Our Studies Work
Parent-To-Be Enrolls in Study
We Gather Info about the Pregnancy
Discoveries & Insights Gained
What’s Involved?
All the information we request will be kept confidential. Your privacy is important to us. We comply with strict regulations
and laws set forth by state and federal agencies as well as the Institutional Review Board (IRB) at the University of
California, San Diego, who oversees and monitors our research. Since we ask for your permission to obtain medical
records, we will also give you detailed information on how this data will be used and how we will protect your privacy.
What is a MotherToBaby Pregnancy Study?
MotherToBaby Pregnancy Studies is a research program seeking to understand how certain medications, vaccines, or health conditions may affect pregnancy. Our research will help people who are pregnant and/or breastfeeding and health providers make informed treatment decisions. All of our studies are observational: we will never ask someone to take or change any aspect of their current health routine.
Who Leads MotherToBaby Pregnancy Studies?
Christina Chambers, PhD, MPH is the lead investigator for MotherToBaby Pregnancy Studies, which are coordinated by UC San Diego’s Center for Better Beginnings. She is a world‐renowned perinatal epidemiologist and a Professor of Pediatrics and Family and Preventive Medicine at the UC San Diego. Her interests are in the areas of birth defects and other pregnancy outcomes, with a special focus on exposures that can cause birth defects.
“Every person deserves to know if their health conditions or the medication they need to take could affect their baby during pregnancy. We are committed to bringing you better information for healthier outcomes.”
– Christina Chambers, PhD, MPH
Join a Kesimpta Study
If you are interested in joining the study, please submit your interest below. Our research team will contact you to see if you qualify. Your information is confidential.
Refer a Patient
If you are a health professional, please fill out the Refer a Patient form and we will contact your patient to see if they qualify. Your information is confidential.